BSE filing, BSE: 532154. Summary written from the filing by ALFA Finder's alert engine.
Johnson Pharmacare Ltd: key numbers
- Share price
- ₹0.37
- Market cap
- ₹20.35 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-55.73 Cr
- P/E (TTM)
- -0.4×Sector 45.2×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Johnson Pharmacare Ltd
All →Johnson Pharmacare Other Announcement
Johnson Pharmacare Limited has approved the shifting of its registered office within the local limits of Ahmedabad. This administrative change was approved at their board meeting.
Johnson Pharmacare Board Meeting Date
Johnson Pharmacare Limited has scheduled a board meeting on August 13, 2026, to consider and approve the standalone unaudited financial results for the quarter ending June 30, 2026.
Johnson Pharmacare Other Announcement
Johnson Pharmacare Ltd has submitted its quarterly shareholding pattern filing for the period ending June 30, 2026, as required by regulatory norms.
Johnson Pharmacare Management Change
Company Secretary Neha Srivastava resigned from the board effective June 11, 2026. The board acknowledges the change with no other material impact.
Johnson Pharmacare Other Announcement
Johnson Pharmacare filed its Annual Secretarial Compliance Report for FY2026. The report notes non-compliances regarding SDD maintenance and the appointment of internal auditors and a CFO.
Johnson Pharmacare Financial Results
Johnson Pharmacare reported audited financial results for the year ended March 31, 2026. The company faces a ₹21.40 Crore debt burden and auditor qualifications regarding internal controls.
- Value
- ₹21.40 Cr
Other debt & borrowing announcements
All →QGO Finance Debt & Borrowing: ₹1 Cr
QGO Finance Ltd has redeemed 100 unlisted non-convertible debentures, with a total value of Rs. 1 Crore, including the principal and applicable interest.
- Value
- ₹1.00 Cr
Capri Global Capital Debt & Borrowing: ₹1.42 Cr
Capri Global paid interest on four listed NCD series ahead of their due dates, totalling Rs.1.42 Crore. The Reg 57 certificate reports no payment changes or delays.
- Value
- ₹1.42 Cr
Ugro Capital Debt & Borrowing: ₹2.99 Cr
Ugro Capital paid Rs 2.99 Crore in interest on two NCD series on 29 October 2026. Payments were made a day before the 30 October due date.
- Value
- ₹2.99 Cr
Time Technoplast Debt & Borrowing: ₹50 Cr
Time Technoplast redeemed its Rs.50 Crore commercial paper in full on maturity on 29 October 2026. The redemption completes servicing of this short-term debt instrument.
- Value
- ₹50.00 Cr
Samvardhana Motherson International Debt & Borrowing: ₹834.8 Cr
Samvardhana Motherson issued a corporate guarantee for a EUR 75 million BNP Paribas term facility of subsidiary MGI B.V. Liability capped at ₹834.75 Crore.
- Value
- ₹834.8 Cr
- Execution
- Guarantee valid up to February 28, 2032
Electrotherm (India) Debt & Borrowing: ₹59.81 Cr
Electrotherm disclosed a Rs 59.81 Crore default on bank loans as at 30 September 2026. The loans were assigned to an ARC under a settlement.
- Value
- ₹59.81 Cr